These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19223058)

  • 1. Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications.
    Kaya T; Swamy N; Persons KS; Ray S; Mohr SC; Ray R
    Bioorg Chem; 2009 Apr; 37(2):57-63. PubMed ID: 19223058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
    Mohr SC; Swamy N; Xu W; Ray R
    Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-specific structural changes in the vitamin D receptor in solution.
    Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
    Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity labeling of the nuclear vitamin D receptor with nonsteroidal alkylating agents.
    Fernández-Gacio A; Fernández-Marcos C; Swamy N; Ray R
    Bioorg Med Chem Lett; 2003 Jan; 13(2):213-6. PubMed ID: 12482426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an affinity-driven cross-linker: isolation of a vitamin D receptor associated factor.
    Swamy N; Addo JK; Ray R
    Bioorg Med Chem Lett; 2000 Feb; 10(4):361-4. PubMed ID: 10714500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C
    J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.
    Wan LY; Zhang YQ; Chen MD; Du YQ; Liu CB; Wu JF
    Molecules; 2015 Nov; 20(11):20473-86. PubMed ID: 26593892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
    Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
    J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided de novo ligand design and docking/molecular dynamics study of vitamin D receptor agonists.
    Shen XL; Takimoto-Kamimura M; Wei J; Gao QZ
    J Mol Model; 2012 Jan; 18(1):203-12. PubMed ID: 21523537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
    Yamamoto K; Anami Y; Itoh T
    Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of vitamin D and VDR model.
    Yamada S; Yamamoto K; Masuno H
    Curr Pharm Des; 2000 May; 6(7):733-48. PubMed ID: 10828304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions.
    Norman AW; Manchand PS; Uskokovic MR; Okamura WH; Takeuchi JA; Bishop JE; Hisatake JI; Koeffler HP; Peleg S
    J Med Chem; 2000 Jul; 43(14):2719-30. PubMed ID: 10893309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301.
    Kakuda S; Okada K; Eguchi H; Takenouchi K; Hakamata W; Kurihara M; Takimoto-Kamimura M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Nov; 64(Pt 11):970-3. PubMed ID: 18997319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and the Anticancer Activity of Vitamin D Receptor Agonists.
    Powała A; Żołek T; Brown G; Kutner A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.